GE HealthCare Technologies GEHC Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 161.5%-2.9pp | 164.4%-1.7pp | 166.1%-0.5pp | 166.6%+0.6pp | 166%+1.3pp | |
| Operating margin | 53.4%-1.1pp | 54.4%+0.1pp | 54.4%+0.7pp | 53.7%+1.2pp | 52.5%+1.3pp | |
| Net margin | 41.4%-1.9pp | 43.3%0.0pp | 43.3%+2.4pp | 40.9%+3.1pp | 37.8%+3.0pp | |
| EBITDA margin | 64.7%-1.1pp | 65.8%-0.1pp | 65.9%+0.5pp | 65.4%+1.0pp | 64.3%+1.1pp | |
| Free cash flow margin | 29.3%— | —— | —— | —— | —— | |
| Returns | ||||||
| Return on equity | 91.2%-7.1pp | 98.3%-3.4pp | 101.7%+2.5pp | 99.2%+4.4pp | 94.8%+4.0pp | |
| Return on assets | 24.4%-1.2pp | 25.6%-0.1pp | 25.7%+1.3pp | 24.4%+1.7pp | 22.7%+1.8pp | |
| Return on invested capital | 44.7%-2.2pp | 47%-0.9pp | 47.8%+1.3pp | 46.5%+2.4pp | 44.2%+2.7pp | |
| Efficiency | ||||||
| Asset turnover | 2.4×0.0× | 2.4×0.0× | 2.4×0.0× | 2.4×0.0× | 2.4×0.0× | |
| Liquidity | ||||||
| Current ratio | 4.9×+0.2× | 4.7×+0.3× | 4.4×0.0× | 4.4×+0.1× | 4.3×-0.1× | |
| Quick ratio | 4×+0.2× | 3.8×+0.3× | 3.5×0.0× | 3.5×+0.1× | 3.4×-0.1× | |
| Leverage | ||||||
| Debt-to-equity | 4.2×0.0× | 4.2×-0.1× | 4.3×-0.2× | 4.5×-0.1× | 4.6×-0.3× | |
| Debt-to-assets | 1.2×0.0× | 1.2×0.0× | 1.2×0.0× | 1.2×0.0× | 1.2×0.0× | |
| Net debt / EBITDA | 12.9×+0.5× | 12.4×+0.2× | 12.2×-0.2× | 12.4×+0.1× | 12.4×-0.4× | |
| Interest coverage | 23.4×+0.7× | 22.6×+1.1× | 21.6×+1.1× | 20.5×+1.3× | 19.2×+0.8× | |
| Per Share | ||||||
| Book value per share | $89.08+3.9% | $85.75+5.2% | $81.49+4.8% | $77.74+5.7% | $73.53+5.6% | |
| Valuation | ||||||
| Market capitalization | $137.09B-3.1% | $141.52B+1.2% | $139.87B-5.8% | $148.47B-1.7% | $151.05B-2.9% | |
| Enterprise value | $179.59B-1.7% | $182.63B+1.5% | $179.89B-4.6% | $188.49B-0.8% | $190B-2.6% | |
| Price / earnings | 65.1×+0.1× | 65×0.0× | 65×-10.1× | 75.1×-7.8× | 82.9×-9.5× | |
| Price / sales | 6.7×-0.3× | 7×0.0× | 7×-0.5× | 7.5×-0.2× | 7.7×-0.3× | |
| Price / book | 13.5×-1.0× | 14.4×-0.6× | 15.1×-1.7× | 16.8×-1.2× | 18×-1.6× | |
| EV / EBITDA | 54.3×-0.8× | 55.1×+0.2× | 54.8×-3.7× | 58.5×-1.7× | 60.2×-2.9× | |
| EV / sales | 8.8×-0.3× | 9.1×0.0× | 9×-0.5× | 9.5×-0.1× | 9.7×-0.3× | |
| Free cash flow yield | 17.5%— | —— | —— | —— | —— | |
| Earnings yield | 24.7%0.0pp | 24.8%0.0pp | 24.8%+2.6pp | 22.2%+2.4pp | 19.8%+2.1pp | |
| Dividend yield | 0.7%0.0pp | 0.7%0.0pp | 0.7%+0.1pp | 0.6%0.0pp | 0.6%0.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are GE HealthCare Technologies's profit margins?
- GE HealthCare Technologies (GEHC) runs a 39.1% gross margin and a 12.6% operating margin, with a 9.1% net margin.
- Where do GE HealthCare Technologies's ratios come from?
- Every ratio is computed from GE HealthCare Technologies's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
